Breast Cancer
-
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
Rethinking the Role of RadiationChest radiation may not be necessary for people with intermediate-risk breast cancer.
by Thomas Celona
-
Understanding the Federal Rule on Breast Tissue Density ReportsScreening mammography reports will include breast density and an explanation in common language.
by Sandra Gordon
-
Forward Look
A More Targeted PARP InhibitorEarly research suggests treatment could have higher potency and less toxicity for people with BRCA-related cancers.
by Marci A. Landsmann
-
Breast Cancer: Making Treatment DecisionsWith additional treatment options and an emphasis on reducing side effects, patients with breast cancer have more decisions to make than ever before.
by Natalie Slivinski
-
Making Cancer a Family AffairInstead of hiding details of her metastatic breast cancer diagnosis from her children, Michelle Audoin opened the door for clear expectations and frank conversations.
by Michelle Audoin
-
Forward Look
Some Breast Cancer Patients Can Skip RadiationResearch suggests postmenopausal women over 50 with low-risk hormone receptor-positive breast cancer may forgo radiation after surgery.
by Darcy Lewis
-
Genetic Testing for Women With Breast CancerNew recommendations clarify when women diagnosed with breast cancer should be offered genetic testing for inherited cancer risk.
by Laura Gesualdi-Gilmore
-
Q&A
A Musical Takes on CancerMusician and breast cancer survivor Marcy Marxer reenacts life during cancer treatment, with a comedic twist.
by Tyler Santora
-
Facts and Stats
Breast Cancer Survival Rates Continue to RiseNew report highlights decades of progress, as well as a persisting disparity.
by Thomas Celona
